Subhrangsu S. Mandal

Affiliations: 
2005- University of Texas at Arlington, Arlington, TX, United States 
Area:
Gene regulation, histone emodification, Epigenetics, noncoding RNA
Website:
https://mentis.uta.edu/explore/profile/subhrangsu-mandal
Google:
"Subhrangsu Mandal"
Mean distance: 8.72
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Chini A, Guha P, Rishi A, et al. (2024) Discovery and functional characterization of LncRNAs associated with inflammation and macrophage activation. Methods (San Diego, Calif.). 227: 1-16
Deb P, Chini A, Guha P, et al. (2023) Dynamic regulation of BDNF gene expression by estradiol and lncRNA HOTAIR. Gene. 148055
Chini A, Guha P, Malladi VS, et al. (2023) Novel long non-coding RNAs associated with inflammation and macrophage activation in human. Scientific Reports. 13: 4036
Aziz MN, Patel A, Iskander A, et al. (2022) One-Pot Synthesis of Novel 2-Imino-5-Arylidine-Thiazolidine Analogues and Evaluation of Their Anti-Proliferative Activity against MCF7 Breast Cancer Cell Line. Molecules (Basel, Switzerland). 27
Price RL, Bhan A, Mandal SS. (2021) HOTAIR beyond repression: In protein degradation, inflammation, DNA damage response, and cell signaling. Dna Repair. 103141
Hussain I, Deb P, Chini A, et al. (2020) HOXA5 Expression Is Elevated in Breast Cancer and Is Transcriptionally Regulated by Estradiol. Frontiers in Genetics. 11: 592436
Obaid M, Udden SMN, Deb P, et al. (2018) LncRNA HOTAIR regulates lipopolysaccharide-induced cytokine expression and inflammatory response in macrophages. Scientific Reports. 8: 15670
Bhan A, Deb P, Shihabeddin N, et al. (2017) Histone methylase MLL1 coordinates with HIF and regulate lncRNA HOTAIR expression under hypoxia. Gene
Bhan A, Soleimani M, Mandal SS. (2017) Long Noncoding RNA and Cancer: A New Paradigm. Cancer Research
Ali A, Kamra M, Bhan A, et al. (2016) New Fe(iii) and Co(ii) salen complexes with pendant distamycins: selective targeting of cancer cells by DNA damage and mitochondrial pathways. Dalton Transactions (Cambridge, England : 2003)
See more...